Nishadil
Signup Signin
Delhi | 25°C (windy)
A Legal Rollercoaster: Corcept's Stock Takes a Dive as Appeals Court Backs Teva in Key Patent Spat

A Legal Rollercoaster: Corcept's Stock Takes a Dive as Appeals Court Backs Teva in Key Patent Spat
Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug

Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug
Lupin Unleashes Affordable Overactive Bladder Treatment in the U.S. Market

Lupin Unleashes Affordable Overactive Bladder Treatment in the U.S. Market
FDA Greenlights Second Generic Abortion Pill, Igniting Fierce Conservative Opposition

FDA Greenlights Second Generic Abortion Pill, Igniting Fierce Conservative Opposition
FDA's Green Light for Generic Abortion Pill Ignites Fiery National Debate

FDA's Green Light for Generic Abortion Pill Ignites Fiery National Debate
Lupin Achieves Major Milestone: USFDA Grants Tentative Approval for Generic HIV Treatment Drug

Lupin Achieves Major Milestone: USFDA Grants Tentative Approval for Generic HIV Treatment Drug
Glenmark Pharma USA Unveils Groundbreaking Generic Antifungal: A New Era in Treatment

Glenmark Pharma USA Unveils Groundbreaking Generic Antifungal: A New Era in Treatment
Load more..